Australian Clinical Labs Limited (ASX:ACL)
Australia flag Australia · Delayed Price · Currency is AUD
2.210
+0.020 (0.91%)
Feb 26, 2026, 3:49 PM AEST

Australian Clinical Labs Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
416540503694922686
Market Cap Growth
-42.92%7.36%-27.51%-24.69%34.33%-
Enterprise Value
7088348051,0011,160940
Last Close Price
2.192.692.343.093.702.67
PE Ratio
15.5416.6621.0319.345.1711.37
Forward PE
12.5413.9413.8315.929.647.42
PS Ratio
0.560.730.721.000.931.06
PB Ratio
2.753.142.834.023.968.38
P/TBV Ratio
-87.9239.9995.8213.75-
P/FCF Ratio
2.653.103.295.083.514.75
P/OCF Ratio
2.532.963.154.833.254.46
PEG Ratio
1.650.743.00---
EV/Sales Ratio
0.961.131.161.441.171.45
EV/EBITDA Ratio
3.4810.2610.5512.564.056.80
EV/EBIT Ratio
10.3212.2712.8715.354.247.34
EV/FCF Ratio
4.524.795.267.324.426.51
Debt / Equity Ratio
2.091.691.741.831.133.71
Debt / EBITDA Ratio
1.551.421.621.680.691.41
Debt / FCF Ratio
2.011.672.022.311.002.11
Net Debt / Equity Ratio
1.931.561.591.711.013.27
Net Debt / EBITDA Ratio
3.583.303.703.710.821.94
Net Debt / FCF Ratio
1.861.541.842.160.891.85
Asset Turnover
1.291.271.191.161.791.52
Inventory Turnover
28.2628.9927.7225.3232.7132.71
Quick Ratio
0.420.440.520.510.530.60
Current Ratio
0.590.560.640.620.640.71
Return on Equity (ROE)
16.68%18.77%13.84%17.79%113.46%80.04%
Return on Assets (ROA)
7.48%7.28%6.67%6.75%30.79%18.82%
Return on Invested Capital (ROIC)
9.94%10.29%8.98%10.40%46.95%29.52%
Return on Capital Employed (ROCE)
18.80%19.00%16.20%16.70%68.00%40.20%
Earnings Yield
6.32%6.00%4.76%5.17%19.34%8.80%
FCF Yield
37.67%32.28%30.42%19.70%28.51%21.04%
Dividend Yield
5.76%4.64%5.14%4.53%14.34%5.33%
Payout Ratio
92.80%76.92%83.35%269.85%13.59%69.57%
Buyback Yield / Dilution
6.50%4.63%0.82%0.18%-32.47%-4.65%
Total Shareholder Return
12.27%9.28%5.95%4.71%-18.13%0.68%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.